{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:40:51Z","timestamp":1791589251007,"version":"4.3.4"},"reference-count":85,"publisher":"Wiley","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EFS2","EFSA Journal"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.2903\/j.efsa.2018.5368","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T08:22:54Z","timestamp":1533284574000},"source":"Crossref","is-referenced-by-count":56,"title":["Scientific opinion on the safety of monacolins in red yeast rice"],"prefix":"10.2903","volume":"16","author":[{"name":"EFSA Panel\u00a0on Food Additives and Nutrient Sources added to Food (ANS)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged","family":"Younes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Aggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Crebelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Dusemund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metka","family":"Filipi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Galtier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Gundert\u2010Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter Georg","family":"Kuhnle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Lambr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Charles","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Therese","family":"Lillegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Moldeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Oskarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ine","family":"Waalkens\u2010Berendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf Antonius","family":"Woutersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Mosesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Restani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Smeraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.2903\/j.efsa.2018.5368_ref1","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1073\/pnas.77.7.3957","article-title":"Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl\u2010coenzyme A reductase and a cholesterol\u2010lowering agent [fungal metabolites\/crystal structure\/absolute configuration\/cholesterol synthesis\/ML\u2010236B (compactin)]","volume":"77","author":"Alberts","year":"1980","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.2903\/j.efsa.2018.5368_ref2","unstructured":"ANSES , 2014. Opinion of the French Agency for Food, Environmental and Occupational Health & Safety. Request n. 2012\u2010SA\u20100228. Available online: https:\/\/www.anses.fr\/en\/system\/files\/NUT2012sa0228EN.pdf [Accessed: 14\u00a0February 2014]"},{"key":"10.2903\/j.efsa.2018.5368_ref3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpba.2014.07.039","article-title":"Chemical profiling and quantification of monacolins and citrinin in red yeast rice commercial raw material and dietary supplements using liquid chromatography\u2010accurate QToF mass spectrometry: chemometrics application","volume":"100","author":"Avula","year":"2014","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.2903\/j.efsa.2018.5368_ref4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","article-title":"Red yeast rice for dyslipidemia in statin\u2010intolerance patients: a randomized trial","volume":"150","author":"Becker","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.2903\/j.efsa.2018.5368_ref5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/14017431003624123","article-title":"HypoCol (red yeast rice) lowers plasma cholesterol \u2013 a randomized placebo controlled study","volume":"44","author":"Bogsrud","year":"2010","journal-title":"Scandinavian Cardiovascular Journal"},{"key":"10.2903\/j.efsa.2018.5368_ref6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/2212798411204020134","article-title":"Fermented foods: patented approaches and formulations for nutritional supplementation and health promotion","volume":"4","author":"Borresen","year":"2012","journal-title":"Recent Patents on Food, Nutrition and Agriculture"},{"key":"10.2903\/j.efsa.2018.5368_ref7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11883-015-0495-8","article-title":"Red yeast rice for the treatment of dyslipidemia","volume":"17","author":"Burke","year":"2015","journal-title":"Current Atherosclerosis Reports"},{"key":"10.2903\/j.efsa.2018.5368_ref8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijfoodmicro.2005.03.002","article-title":"Study on red fermented rice with high concentration of monacolin K and low concentration of citrinin","volume":"103","author":"Chen","year":"2005","journal-title":"International Journal of Food Microbiology"},{"key":"10.2903\/j.efsa.2018.5368_ref9","doi-asserted-by":"crossref","first-page":"127043","DOI":"10.1155\/2012\/127043","article-title":"Interaction between Red Yeast Rice and CYP450 enzymes\/P\u2010Glycoprotein and its implication for clinical pharmacokinetics of lovastatin","volume":"2012","author":"Chen","year":"2012","journal-title":"Evidence\u2010Based Complementary and Alternative Medicine"},{"key":"10.2903\/j.efsa.2018.5368_ref10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2013.01.028","article-title":"Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products","volume":"444","author":"Chen","year":"2013","journal-title":"The International Journal of Pharmaceutics"},{"key":"10.2903\/j.efsa.2018.5368_ref11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/1541-4337.12145","article-title":"Edible filamentous fungi from the species Monascus: early traditional fermentations, modern molecular biology, and future genomics","volume":"14","author":"Chen","year":"2015","journal-title":"Comprehensive Reviews in Food Science and Food Safety"},{"key":"10.2903\/j.efsa.2018.5368_ref12","first-page":"128","article-title":"Is red\u2010yeast rice a safe and effective alternative to ststins?","volume":"64","author":"Chen","year":"2015","journal-title":"The Journal of Family Practice"},{"key":"10.2903\/j.efsa.2018.5368_ref13","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1039\/C7SC00475C","article-title":"Orange, red, yellow: biosynthesis of azaphilone pigments in Monascus fungi","volume":"8","author":"Chen","year":"2017","journal-title":"Chemical Science"},{"key":"10.2903\/j.efsa.2018.5368_ref14","unstructured":"Chinese Medical Herbology and Pharmacology , 2004. Hong Qu (Monascus). In: Chen JK and Chen TT (eds.). Art of Medicine Press Inc. Chap. 9."},{"key":"10.2903\/j.efsa.2018.5368_ref15","unstructured":"Chinese Ministry of Public Health , 2015. Chinese standards for food Additives \u2010 GB 2760\u20102015. Translated by: USDA Foreign Agricultural Services. \u201c8 April 20165. Available online: https:\/\/gain.fas.usda.gov\/Recent%20GAIN%20Publications\/Standard%20for%20Food%20Additive%20Use%20-%20GB2760-2015_Beijing_China%20-%20Peoples%20Republic%20of_4-28-2015.pdf"},{"key":"10.2903\/j.efsa.2018.5368_ref16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1177\/2047487317715714","article-title":"Variability in strength or red yeast rice supplements purchased from mainstream retailers","volume":"24","author":"Cohen","year":"2017","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.2903\/j.efsa.2018.5368_ref17","first-page":"149","article-title":"\u00c9tude Mona Lisa Effet d'une pr\u00e9paration de levure rouge de riz (Art\u00e9chol\u00ae) dans une cohorte de patients hypercholest\u00e9rol\u00e9miques trait\u00e9s par des m\u00e9decins g\u00e9n\u00e9ralistes","volume":"132","author":"Descamps","year":"2013","journal-title":"Louvain Medical"},{"key":"10.2903\/j.efsa.2018.5368_ref18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0002-9149(01)01464-3","article-title":"Air Force\/Texas Coronary Atherosclerosis Prevention Study (AFCAPS\/TexCAPS): additional perspectives on tolerability of long\u2010term treatment with lovastatin","volume":"87","author":"Downs","year":"2001","journal-title":"American Journal of Cardiology"},{"key":"10.2903\/j.efsa.2018.5368_ref19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0090-9556(25)08739-2","article-title":"The physiological disposition of lovastatin","volume":"17","author":"Duggan","year":"1989","journal-title":"Drug Metabolism and Disposition"},{"key":"10.2903\/j.efsa.2018.5368_ref20","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/0002-9343(91)90053-Z","article-title":"Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin","volume":"91","author":"Dujovne","year":"1991","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.2903\/j.efsa.2018.5368_ref21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2903\/j.efsa.2009.1051","article-title":"Transparency in Risk Assessment \u2013 Scientific Aspects Guidance of the Scientific Committee on Transparency in the Scientific Aspects of Risk Assessments carried out by EFSA. Part 2: General Principles","volume":"7","author":"EFSA","year":"2009","journal-title":"EFSA Journal"},{"issue":"3","key":"10.2903\/j.efsa.2018.5368_ref22","first-page":"2605","article-title":"Scientific Opinion on the risks for public and animal health related to the presence of citrinin in food and feed1, EFSA Panel\u00a0on Contaminants in the Food Chain (CONTAM)","volume":"10","author":"EFSA CONTAM panel","year":"2012","journal-title":"EFSA Journal"},{"issue":"7","key":"10.2903\/j.efsa.2018.5368_ref23","first-page":"2304","article-title":"Scientific Opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL\u2010cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No. 1924\/2006","volume":"9","author":"EFSA NDA Panel","year":"2011","journal-title":"EFSA Journal"},{"issue":"2","key":"10.2903\/j.efsa.2018.5368_ref24","first-page":"3084","article-title":"Scientific Opinion on the substantiation of a health claim related to monacolin K in SYLVAN BIO red yeast rice and maintenance of normal blood LDL\u2010cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924\/2006","volume":"11","author":"EFSA NDA Panel","year":"2013","journal-title":"EFSA Journal"},{"issue":"9","key":"10.2903\/j.efsa.2018.5368_ref25","first-page":"1249","article-title":"Guidance on Safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements","volume":"7","author":"EFSA Scientific Committee","year":"2009","journal-title":"EFSA Journal"},{"key":"10.2903\/j.efsa.2018.5368_ref26","unstructured":"FDA , 2014. Warning letter FLA\u201014\u201010 dated April, 2014. Available online: https:\/\/www.fda.gov\/ICECI\/EnforcementActions\/WarningLetters\/ucm396822.htm. [Accessed: 12\u20102017]"},{"key":"10.2903\/j.efsa.2018.5368_ref27","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1016\/S0021-9258(18)99642-0","article-title":"Purification and properties of an enzyme in human blood and rat liver microsomes catalyzing the formation and hydrolysis of gammalactones. II. Metal ion effects, kinetics, and equilibra","volume":"241","author":"Fishbein","year":"1966","journal-title":"The Journal of Biological Chemistry"},{"key":"10.2903\/j.efsa.2018.5368_ref28","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.90.4.1679","article-title":"Effect of lovastatin on early carotid atherosclerosis and cardiovascular events","volume":"90","author":"Furberg","year":"1994","journal-title":"Circulation"},{"key":"10.2903\/j.efsa.2018.5368_ref29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.04.004","article-title":"Traditional Chinese lipid\u2010lowering agent red yeast rice results in significant LDL reduction but safety is uncertain \u2010 A systematic review and meta\u2010analysis","volume":"240","author":"Gerards","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.2903\/j.efsa.2018.5368_ref30","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/archinternmed.2010.382","article-title":"Market variability of monacolin levels in commercial red yeast rice products","volume":"170","author":"Gordon","year":"2010","journal-title":"Archives of Internal Medicine"},{"key":"10.2903\/j.efsa.2018.5368_ref31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.51847\/QmZ5byR","article-title":"A review on lovastatin and its production","volume":"4","author":"Goswami","year":"2012","journal-title":"Journal of Biochemical Technology"},{"key":"10.2903\/j.efsa.2018.5368_ref32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0090-9556(25)07025-4","article-title":"Metabolism of lovastatin by rat and human liver microsomes in\u00a0vitro","volume":"16","author":"Greenspan","year":"1988","journal-title":"Drug Metabolism and Disposition"},{"key":"10.2903\/j.efsa.2018.5368_ref33","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jhep.2009.02.021","article-title":"Acute hepatitis caused by a natural lipid\u2010lowering product: When \u201calternative\u201d medicine is no \u201calternative at all","volume":"50","author":"Grieco","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.2903\/j.efsa.2018.5368_ref34","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0090-9556(25)08192-9","article-title":"Biotransformation of lovastatin. V. Species differences in in\u00a0vivo metabolite profiles of mouse, rat, dog, and human","volume":"21","author":"Halpin","year":"1993","journal-title":"Drug Metabolism and Disposition"},{"key":"10.2903\/j.efsa.2018.5368_ref35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1071\/BT9830051","article-title":"A new taxonomy for Monascus species based on cultural and microscopical characters","volume":"31","author":"Hawksworth","year":"1983","journal-title":"Australian Journal of Botany"},{"key":"10.2903\/j.efsa.2018.5368_ref36","unstructured":"Health Canada , 2014. Notice. Prescription drug list (PDL): Lovastatin. File number 14\u2010105859\u201093, dated June 4, 2014. Available at: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/public-involvement-consultations\/drug-products\/notice-prescription-drug-list-lovastatin.html?_ga=2.175840228.773901738.1501236921-557739232.1501236921"},{"key":"10.2903\/j.efsa.2018.5368_ref37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ajcn\/69.2.231","article-title":"Cholesterol\u2010lowering effects of a proprietary Chinese red\u2010yeast\u2010rice dietary supplement","volume":"69","author":"Heber","year":"1999","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.2903\/j.efsa.2018.5368_ref38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.nutres.2016.07.005","article-title":"Low daily dose of 3 mg monacolin k from RYR reduces the concentration of LDL\u2010C in a randomized\u2010controlled intervention","volume":"36","author":"Heinz","year":"2016","journal-title":"Nutrition Research"},{"key":"10.2903\/j.efsa.2018.5368_ref39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/HJR.0b013e32801da137","article-title":"Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients","volume":"14","author":"Huang","year":"2007","journal-title":"The European Journal of Cardiovascular Prevention & Rehabilitation"},{"key":"10.2903\/j.efsa.2018.5368_ref40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0009-9236(98)90034-0","article-title":"Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid","volume":"63","author":"Kantola","year":"1998","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.2903\/j.efsa.2018.5368_ref41","first-page":"313","article-title":"Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative theraphy for hyperlipidemia","volume":"34","author":"Klimek","year":"2009","journal-title":"Pharmacy and Therapeutics"},{"key":"10.2903\/j.efsa.2018.5368_ref42","doi-asserted-by":"crossref","unstructured":"Kumari S, Sherriff M, Spooner D and Beckett R, 2013. Peripheral neuropathy induced by red yeast rice in a patient with a known small bowel gastrointestinal tumour. BMJ Case Reports, https:\/\/doi.org\/10.1136\/bcr-2013-009060","DOI":"10.1136\/bcr-2013-009060"},{"key":"10.2903\/j.efsa.2018.5368_ref43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2125.2008.03224.x","article-title":"Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products","volume":"66","author":"Lapi","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.2903\/j.efsa.2018.5368_ref44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","article-title":"Pharmacodynamics and pharmacokinetics of the HMN\u2010CoA reductase inhibitors","volume":"32","author":"Lennern\u00e4s","year":"1997","journal-title":"Clinical Pharmacokinetics"},{"key":"10.2903\/j.efsa.2018.5368_ref45","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jpba.2004.04.004","article-title":"Identification and chemical profiling of monacolins in red yeast rice using high\u2010performance liquid chromatography with photodiode array detector and mass spectrometry","volume":"35","author":"Li","year":"2004","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.2903\/j.efsa.2018.5368_ref46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/acm.2005.11.1031","article-title":"Plasma clearance of lovastatin versus Chinese Red Yeast Rice in healthy volunteers","volume":"11","author":"Li","year":"2005","journal-title":"Journal of Alternative and Complementary Medicine"},{"key":"10.2903\/j.efsa.2018.5368_ref47","doi-asserted-by":"crossref","first-page":"e98611","DOI":"10.1371\/journal.pone.0098611","article-title":"A meta\u2010analysis of red yeast Rice: an effective and relatively safe alternative approach for dyslipidemia","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"key":"10.2903\/j.efsa.2018.5368_ref48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.foodcont.2013.10.016","article-title":"Incidence of citrinin in red yeast rice and various commercial Monascus products in Taiwan from 2009 to 2012","volume":"38","author":"Liao","year":"2014","journal-title":"Food Control"},{"key":"10.2903\/j.efsa.2018.5368_ref49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/eje.1.02012","article-title":"Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia","volume":"153","author":"Lin","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.2903\/j.efsa.2018.5368_ref50","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00253-007-1256-6","article-title":"Biologically active components and nutraceuticals in the Monascus\u2010fermented rice: a review","volume":"77","author":"Lin","year":"2008","journal-title":"Applied Microbiology and Biotechnology"},{"key":"10.2903\/j.efsa.2018.5368_ref51","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ptr.6025","article-title":"A case of erectile dysfunction induced by red yeast rice in lipid\u2010lowering therapy","volume":"32","author":"Liu","year":"2018","journal-title":"Phytotherapy Research"},{"key":"10.2903\/j.efsa.2018.5368_ref52","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1021\/jf000338c","article-title":"Constituents of red yeast rice, a traditional Chinese food and medicine","volume":"48","author":"Ma","year":"2000","journal-title":"Journal of Agricultural and Food Chemistry"},{"issue":"Suppl. 2","key":"10.2903\/j.efsa.2018.5368_ref53","first-page":"26","article-title":"The toxicology of HMG\u2013CoA reductase inhibitors: prediction of human risk toxicologic","volume":"32","author":"Macdonald","year":"2004","journal-title":"Pathology"},{"key":"10.2903\/j.efsa.2018.5368_ref54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/026520399284280","article-title":"Biological activities of oligoketide pigments of Monascus purpureus","volume":"16","author":"Mart\u00ednkov\u00e1","year":"1999","journal-title":"Food Additives and Contaminants"},{"key":"10.2903\/j.efsa.2018.5368_ref55","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1021\/jf304881g","article-title":"Development of a rapid LC\/DAD\/FLD\/MSn method for the simultaneous determination of monacolins and citrinin in red fermented rice products","volume":"61","author":"Mornar","year":"2013","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.2903\/j.efsa.2018.5368_ref56","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/bcp.13171","article-title":"Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system","volume":"83","author":"Mazzanti","year":"2017","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.2903\/j.efsa.2018.5368_ref57","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-145-6-200609190-00021","article-title":"Symptomatic myopathy due to red yeast rice","volume":"145","author":"Mueller","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"10.2903\/j.efsa.2018.5368_ref58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.foodchem.2012.10.104","article-title":"Simultaneous determination of lovastatin and citrinin in red yeast rice supplements by micellar electrokinetic capillary chromatography","volume":"138","author":"Nigovi\u0107","year":"2013","journal-title":"Food Chemistry"},{"key":"10.2903\/j.efsa.2018.5368_ref59","unstructured":"NIH , 2015. Red Yeast Rice. National Center for Complementary and Integrative Health, NIH. Available online: https:\/\/nccih.nih.gov\/sites\/nccam.nih.gov\/files\/Red_Yeast_Rice_11-30-2015.pdf [Accessed: 12\u20102017]"},{"key":"10.2903\/j.efsa.2018.5368_ref60","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11101-010-9171-3","article-title":"Azaphilones: a class of fungal metabolites with diverse biological activities","volume":"9","author":"Osmanova","year":"2010","journal-title":"Phytochemistry Reviews"},{"key":"10.2903\/j.efsa.2018.5368_ref61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10295-012-1216-8","article-title":"Monascus secondary metabolites: production and biological activity","volume":"40","author":"Patakova","year":"2013","journal-title":"Journal of Industrial Microbiology and Biotechnology"},{"key":"10.2903\/j.efsa.2018.5368_ref62","doi-asserted-by":"crossref","unstructured":"Philibert C, Bres V, Jea\u2010Pastor M\u2010J, Guy C, Lebrun\u2010Vignes B, Robin P, Pinzani V and Hillaire\u2010Buys D, 2016. Atteites musculaires et levure de riz rouge: analyse des donn\u00e9es de la base national de pharmacovigilance et revue de la litt\u00e9rature. Th\u00e9rapie, https:\/\/doi.org\/10.2515\/therapie\/2015053","DOI":"10.2515\/therapie\/2015053"},{"key":"10.2903\/j.efsa.2018.5368_ref63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacl.2007.12.005","article-title":"A case report from consumption of red yeast rice","volume":"2","author":"Polsani","year":"2008","journal-title":"Journal of Clinical Lipidology"},{"key":"10.2903\/j.efsa.2018.5368_ref64","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/00007890-200210270-00028","article-title":"Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient","volume":"74","author":"Prasad","year":"2002","journal-title":"Transplantation"},{"key":"10.2903\/j.efsa.2018.5368_ref65","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-149-7-200810070-00021","article-title":"Symptomatic hepatitis associated with the use of herbel red yeast rice","volume":"149","author":"Roselle","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.2903\/j.efsa.2018.5368_ref66","first-page":"324","article-title":"Treatment of dyslipidemia with statins and physical exercises. Recent findings of skeletal muscle responses","volume":"104","author":"Rotta Bonfim","year":"2015","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"10.2903\/j.efsa.2018.5368_ref67","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/1574886311666160201152047","article-title":"When nutraceuticals reinforce drugs side effects: a case report","volume":"11","author":"Russo","year":"2016","journal-title":"Current Drug Safety"},{"key":"10.2903\/j.efsa.2018.5368_ref68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1383-5718(99)00095-9","article-title":"Mutagenicity of commercial Monascus fermentation products and the role of citrinin contamination","volume":"444","author":"Sabater\u2010Vilar","year":"1999","journal-title":"Mutation Reserach"},{"key":"10.2903\/j.efsa.2018.5368_ref69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2004","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"10.2903\/j.efsa.2018.5368_ref70","first-page":"1481","article-title":"Food\u2010Drug Interactions","volume":"62","author":"Schmidt","year":"2002","journal-title":"Drug Metabolism and Disposition"},{"key":"10.2903\/j.efsa.2018.5368_ref71","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/jps.2600800905","article-title":"Relative lipophilicities, solubilities, and structure\u2010pharmacological considerations of 3\u2010hydroxy\u20103\u2010methylglutaryl\u2010coenzyme a (HMG\u2010COA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin","volume":"80","author":"Serajuddin","year":"1991","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.2903\/j.efsa.2018.5368_ref72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","article-title":"The pharmacology of statins","volume":"88","author":"Sirtori","year":"2014","journal-title":"Pharmacological Research"},{"key":"10.2903\/j.efsa.2018.5368_ref73","unstructured":"SKLM (Permanent Senate Commission on Food Safety), 2012. Toxicological evaluation of red mould rice: An update. Issued on December 18th 2012. Available at:\u00a0http:\/\/www.dfg.de\/download\/pdf\/dfg_im_profil\/reden_stellungnahmen\/2013\/131206_sklm_red_mould_rice_update.pdf."},{"key":"10.2903\/j.efsa.2018.5368_ref74","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/01.SMJ.0000100117.79718.DC","article-title":"Chinese red rice\u2010induced myopathy","volume":"96","author":"Smith","year":"2003","journal-title":"Southern Medical Journal"},{"key":"10.2903\/j.efsa.2018.5368_ref76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.2903\/j.efsa.2018.5368_ref77","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/dta.1929","article-title":"Pharmacologically effective red yeast rice preparations marketed as dietary supplements illustrated by a case report","volume":"8","author":"Venhuis","year":"2016","journal-title":"Drug Testing and Analysis"},{"key":"10.2903\/j.efsa.2018.5368_ref78","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1532-5415.2006.00668_7.x","article-title":"Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment","volume":"54","author":"Vercelli","year":"2006","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.2903\/j.efsa.2018.5368_ref79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0090-9556(25)07606-8","article-title":"Biotransformation of lovastatin. I. Structure elucidation of in\u00a0vitro and in\u00a0vivo metabolites in the rat and mouse","volume":"18","author":"Vyas","year":"1990","journal-title":"Drug Metabolism and Disposition"},{"key":"10.2903\/j.efsa.2018.5368_ref80","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0090-9556(25)07608-1","article-title":"Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P\u2010450 in dehydrogenation of lovastatin","volume":"18","author":"Vyas","year":"1990","journal-title":"Drug Metabolism and Disposition"},{"key":"10.2903\/j.efsa.2018.5368_ref81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0003-9861(91)90551-S","article-title":"Biotransformation of lovastatin: IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes","volume":"290","author":"Wang","year":"1991","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.2903\/j.efsa.2018.5368_ref82","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1021\/jf049783o","article-title":"Modified method for screening low\u2010citrinin\u2010producing strains of Monascus purpureus on rice culture","volume":"52","author":"Wang","year":"2004","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.2903\/j.efsa.2018.5368_ref83","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bionut.2013.08.003","article-title":"Red azaphilone pigments extracted from red yeast rice induces cellular senescence and reduces viability in HepG2 cells","volume":"3","author":"Wei","year":"2013","journal-title":"Biomedicine Preventive Nutrition"},{"key":"10.2903\/j.efsa.2018.5368_ref84","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJM199411173312002","article-title":"Lack of effect of lovastatin on restenosis after coronary angioplasty","volume":"331","author":"Weintraub","year":"1994","journal-title":"The New England Journal of Medicine"},{"key":"10.2903\/j.efsa.2018.5368_ref85","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1034\/j.1398-9995.1999.00374.x","article-title":"Anaphylaxis due to Monascus purpureus\u2010fermented rice (red yeast rice)","volume":"54","author":"Wigger\u2010Alberti","year":"1999","journal-title":"Allergy"},{"key":"10.2903\/j.efsa.2018.5368_ref86","doi-asserted-by":"crossref","unstructured":"Zhang ML, Peng C\u2010X and Zhou Y\u2010F, 2000. Methods and compositions employing red rice fermentation products. US Patent n 6,046,022, dated April 4th, 2000.","DOI":"10.1088\/1126-6708\/2000\/02\/022"}],"container-title":["EFSA Journal"],"original-title":[],"link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.2903\/j.efsa.2018.5368","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.2903\/j.efsa.2018.5368\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T01:55:40Z","timestamp":1751766940000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.2903\/j.efsa.2018.5368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":85,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.2903\/j.efsa.2018.5368","relation":{},"ISSN":["1831-4732","1831-4732"],"issn-type":[{"value":"1831-4732","type":"print"},{"value":"1831-4732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}